인데놀정10mg(프로프라놀롤염산염)

Recall Summary Indanol 10mg tablets (propranolol hydrochloride) manufactured by Dongkwang Pharmaceutical are being recalled in South Korea because they contain higher-than-acceptable levels of N-nitroso-propranolol impurity. This is a Class II recall affecting multiple batch numbers of this blood pressure medication. The recall applies to products distributed in South Korea.

Recalling firm
동광제약(주)
Product
인데놀정10mg(프로프라놀롤염산염) (Barcode: 8806459024701, 8806459024718, 8806459024725, 8806459024732)
Reason
불순물(N-nitroso-propranolol)허용기준초과검출에따른영업자회수
Classification
Class II
Category
drug recall
Country
South Korea
Agency
MFDS-DRUG
Recall date
2026-05-29
Status
Ongoing
Distribution
South Korea

Official recall notice from MFDS-DRUG

Recall details on Nibble Recalls: https://trynibble.app/recalls/9b838451-95ae-4b9d-9eae-6487293316b7